Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Paraplatin 150mg/15ml solution for infusion vials
0801050F0BBAEAE
|
Paraplatin | Carboplatin | Malignant Disease and Immunosuppression | No data available |
|
Paraplatin 450mg/45ml solution for infusion vials
0801050F0BBAFAF
|
Paraplatin | Carboplatin | Malignant Disease and Immunosuppression | No data available |
|
Paraplatin 50mg/5ml solution for infusion vials
0801050F0BBADAD
|
Paraplatin | Carboplatin | Malignant Disease and Immunosuppression | No data available |
|
Paraplatin 600mg/60ml solution for infusion vials
0801050F0BBAGAG
|
Paraplatin | Carboplatin | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 10mg inj vials
0803043Q0AAAGAG
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 20mg inj vials
0803043Q0AAADAD
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 300micrograms/1ml inj ampoules
0803043Q0AAAAAA
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 30mg inj vials
0803043Q0AAAHAH
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 40mg inj vials
0803043Q0AAAEAE
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 600micrograms/1ml inj ampoules
0803043Q0AAABAB
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 60mg inj vials
0803043Q0AAAFAF
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 900micrograms/1ml inj ampoules
0803043Q0AAACAC
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Paxene 100mg/16.7ml solution for infusion vials
0801050V0BCABAB
|
Paxene | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paxene 150mg/25ml solution for infusion vials
0801050V0BCACAC
|
Paxene | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paxene 300mg/50ml solution for infusion vials
0801050V0BCADAD
|
Paxene | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Paxene 30mg/5ml solution for infusion vials
0801050V0BCAAAA
|
Paxene | Paclitaxel | Malignant Disease and Immunosuppression | No data available |
|
Pazopanib 200mg tablets
0801050AZAAAAAA
|
Pazopanib | Pazopanib | Malignant Disease and Immunosuppression | No data available |
|
Pazopanib 400mg tablets
0801050AZAAABAB
|
Pazopanib | Pazopanib | Malignant Disease and Immunosuppression | No data available |
|
Pegaspargase 3,750units inj vials
0801050BAAAABAB
|
Pegaspargase | Pegaspargase | Malignant Disease and Immunosuppression | No data available |
|
Pegaspargase 3,750units/5ml solution for injection vials
0801050BAAAAAAA
|
Pegaspargase | Pegaspargase | Malignant Disease and Immunosuppression | No data available |
|
Pegasys 135micrograms/0.5ml inj pre-filled pens
0802040A0BDACAM
|
Pegasys | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Pegasys 180micrograms/0.5ml inj pre-filled pens
0802040A0BDADAN
|
Pegasys | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Pegasys 180micrograms/0.5ml inj pre-filled syringes
0802040A0BDAAAF
|
Pegasys | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2a 135micrograms/0.5ml inj pf dispos dev
0802040A0AAAMAM
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2a 135micrograms/0.5ml inj pfs
0802040A0AAAGAG
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.